Creating a differentiated brand and proposition for a game-changing innovator

atbtherapeutics is a pioneering biopharmaceutical company committed to providing novel therapeutic solutions for patients with hard-to-treat cancer.

Their atbody innovation is a novel therapeutic format that can only be achieved using atb’s proprietary, plant-based technology and is designed to become a game-changer format in antibody-based targeted therapies.

We developed a strongly differentiated proposition with a contemporary and engaging brand identity, supported by a messaging platform that focuses on the positive effects and benefits rather than the technology. The final positioning presents atbtherapeutics as a disruptive entrant to the market with an innovative approach delivered through transformative assets and technology.